Article

Differences between intrinsic and acquired nucleoside analogue resistance in acute myeloid leukaemia cells

2021-07-20

Abstract excerpt

<h4>Summary</h4> <h4>Background</h4> SAMHD1 mediates resistance to anti-cancer nucleoside analogues, including cytarabine, decitabine, and nelarabine that are commonly used for the treatment of leukaemia, through cleavage of their triphosphorylated forms. Hence, SAMHD1 inhibitors are promising candidates for the sensitisation of leukaemia cells to nucleoside analogue-based therapy. Here, we investigated the effe...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: a8e04b0c-b623-52de-ae9f-1819675a41ca
DOI: 10.1101/2021.07.19.452885

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Differences between intrinsic and acquired nucleoside analogue resistance in acute myeloid leukaemia cellsDOI 10.1101/2021.07.19.452885Read

Differences between intrinsic and acquired nucleoside analogue resistance in acute myeloid leukaemia cellsSemantic proximity Read

Defective Nucleotide Catabolism Defines a Subset of Cancers Sensitive to Purine Nucleoside Phosphorylase InhibitionSemantic proximity Read

SAMHD1 is a key regulator of the lineage-specific response of acute lymphoblastic leukaemias to nelarabineSemantic proximity Read

SAMHD1 is a key regulator of the lineage-specific response of acute lymphoblastic leukaemias to nelarabineSemantic proximity Read

With me or against me: Tumor suppressor and drug resistance activities of SAMHD1.Semantic proximity Read

Acquired Resistance to Decitabine Associated with the Deoxycytidine Kinase A180P Mutation: Implications for the Order of Hypomethylating Agents in Myeloid Malignancies TreatmentSemantic proximity Read

<i>SAMHD1</i> mutations in mantle cell lymphoma are recurrent and confer <i>in vitro</i> resistance to nucleoside analoguesSemantic proximity Read

SAMHD1 limits the efficacy of forodesine in leukaemia by protecting cells against cytotoxicity of dGTPSemantic proximity Read

Stabilization of SAMHD1 by NONO is crucial for Ara-C resistance in AMLSemantic proximity Read

Clofarabine exerts antileukemic activity against cytarabine-resistant B-cell precursor acute lymphoblastic leukemia with low deoxycytidine kinase expression.Semantic proximity Read

Comprehensive comparison between azacytidine and decitabine treatment in an acute myeloid leukemia cell lineSemantic proximity Read

SAMHD1 controls nucleoside-based cancer therapeutics, deoxyguanosine toxicity, and inflammationSemantic proximity Read